Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Metabolism: Clinical and Experimental|July 1, 1985
Discordance of plasma DHEA-S, DHEA, and cortisol responses with various ACTH regimensG T Griffing, J Allen, H Pratt, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
19-Nor-corticosteroids in experimental and human hypertensionJ C Melby, S L Dale, M Holbrook, et al.
Clinical Physiology and Biochemistry|January 1, 1988
Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedioneG T Griffing, M Holbrook, J C Melby, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1987
Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive ratJ C Melby, M Holbrook, G T Griffing, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1991
Antihypertensive effects of an aromatase inhibitor in inbred salt-sensitive ratsG T Griffing, J C Melby, M Holbrook, et al.
Journal of Clinical Pharmacology|November 1, 1982
The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndromeG T Griffing, S A Aurecchia, B H Sindler, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1983
Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertensionG T Griffing, S L Dale, M M Holbrook, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndromeM E Ehlers, G T Griffing, T E Wilson, et al.
Journal of Steroid Biochemistry|November 1, 1989
Renal 21-hydroxylation of 19-hydroxy-progesterone to 19-hydroxy-deoxycorticosteroneG T Griffing, M M Holbrook, F A Bencsath, et al.
Pageof 11